Study on Neoantigen-specific T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) | Clinical Trial

Study on Neoantigen-specific T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) | Clinical Trial | Right2Hope